In ₹ Crore except Per Share 12 Months Ending | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | |
|---|---|---|---|---|---|---|
| Other Income | -56.5 | 1.6 | 17.9 | 6.6 | -24.8 | |
| Revenue Detail — as filed | ||||||
| + Operating Income | 1,564.7 | 1,308.4 | 1,538.1 | 1,549.5 | 2,077.7 | |
| + Income from Investments (net) | 93.8 | 86.8 | 98.1 | 89.3 | 130.5 | |
| Expense Detail — as filed | ||||||
| + Employee Remuneration & Welfare | 142.3 | 166.2 | 165.5 | 188.9 | 154.7 | |
| + Commission (net) | 295.5 | 259.8 | 279.8 | 317.6 | 369.5 | |
| + Commission & Brokerage (net) | 295.5 | 259.8 | 279.8 | 317.6 | 369.5 | |
| + Non-operating Expense | -49.7 | 10.5 | 27.2 | 20.2 | -21.8 | |
| + Non-operating Provision — Doubtful Debts | -1.3 | 2.0 | 2.4 | 5.3 | -5.2 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | ||||||
| Profit before Extraordinary Items | 206.1 | -91.4 | -35.3 | -87.6 | 341.2 | |
| Profit / (Loss) before Tax — alt tag | 206.1 | -91.4 | -35.3 | -87.6 | 341.2 | |
| + Provision for Tax | 0.0 | 0.0 | 0.0 | 0.0 | -4.0 | |
| Profit / (Loss) after Tax | 206.1 | -91.4 | -35.3 | -87.6 | 345.1 | |
| Profit Carried to Balance Sheet | -718.5 | -809.9 | -845.2 | -932.8 | -587.7 | |
| Per Share — as-filed variants | ||||||
| Basic & Diluted EPS before Extraordinary (not annualised) | 1.13 | -0.50 | -0.19 | -0.47 | 1.87 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | 1.13 | -0.50 | -0.19 | -0.47 | 1.87 | |
| Appropriations & Transfers | ||||||
| + Transfer to Profit & Loss Account | 94.9 | -145.2 | -62.0 | -135.5 | 282.5 | |
| Reserves & Surplus excl. Revaluation Reserve | 1,231.3 | 1,142.6 | 1,110.0 | 1,024.2 | 1,371.5 | |
| Insurance — Revenue Account (Policyholders') | ||||||
| Premium Earned | 1,527.4 | 1,220.0 | 1,422.1 | 1,453.6 | 1,972.0 | |
| + Gross Premiums Written | 2,078.7 | 1,631.9 | 1,843.1 | 2,231.3 | 2,879.7 | |
| + Net Premium Written | 1,672.1 | 1,287.9 | 1,450.1 | 1,766.7 | 2,301.7 | |
| + Operating Expenses — Insurance Business | 312.7 | 243.9 | 307.7 | 316.6 | 306.4 | |
| + Non-operating Expenses — Non-insurance | -48.4 | 8.4 | 24.7 | 14.9 | -16.6 | |
| + Claims Paid | 824.6 | 849.6 | 960.8 | 946.4 | 1,052.3 | |
| + Incurred Claims | 861.6 | 949.9 | 1,012.6 | 1,050.9 | 1,119.2 | |
| + Change in Outstanding Claims | 37.0 | 100.4 | 51.7 | 104.5 | 66.9 | |
| Insurance — Shareholders' Account | ||||||
| + Income — Shareholders' Account | 156.4 | -81.0 | -8.1 | -67.5 | 319.4 | |
| + Shareholders' Investment Income | 49.6 | 64.2 | 53.9 | 68.1 | 36.1 | |
| + Transfer from Policyholders' Fund | 94.9 | -145.2 | -62.0 | -135.5 | 282.5 | |
| With Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | -0.0 | |
| Without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Insurance — Fund NPAs | ||||||
| + Gross NPAs — Policyholders' Fund | 54.3 | 50.0 | 50.0 | 50.0 | 50.0 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | ||||||
| Solvency Ratio | 3.03 | 2.86 | 2.85 | 2.49 | 2.49 | |
| Combined Ratio | 0.93 | 1.17 | 1.12 | 1.08 | 0.86 | |
| Incurred Claim Ratio | 0.56 | 0.78 | 0.71 | 0.72 | 0.57 | |
| Net Retention Ratio | 0.80 | 0.79 | 0.79 | 0.79 | 0.80 | |
| Expenses of Management Ratio | 0.36 | 0.38 | 0.39 | 0.33 | 0.28 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | ||||||
| Investor Complaints — During the Period | -4.00 | -1.00 | 0.00 | 0.00 | 0.00 | |
| Investor Complaints — Received | 14.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Investor Complaints — Disposed | 18.00 | 1.00 | 0.00 | 0.00 | 0.00 | |
| Related-party Transactions — During the Period | — | — | — | — | 7.4 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||||
| Operating Expenses | 1,469.8 | 1,453.6 | 1,600.1 | 1,685.1 | 1,795.1 | |
| Other Operating Expenses | 170.4 | 77.7 | 142.2 | 127.7 | 151.7 | |